Holen Sie sich die Stockscreener-App
61.98
1.05%
-0.66
Handel nachbörslich:
62.00
0.02
+0.03%
Bridgebio Pharma Inc Aktie (BBIO) Neueste Nachrichten
Are Shares of BridgeBio Pharma Still a Bargain After 146% Rally and Clinical Trial Buzz? - Yahoo Finance
Mizuho Boosts Price Target on BridgeBio Pharma to $91 From $64, Keeps Outperform Rating - MarketScreener
Using Bollinger Bands to evaluate BridgeBio Pharma Inc.M&A Rumor & Real-Time Volume Trigger Notifications - newser.com
BBIO: HC Wainwright & Co. Reiterates Buy Rating with $90 PT | BB - GuruFocus
Real time alert setup for BridgeBio Pharma Inc. performance2025 EndofYear Setup & Expert Verified Movement Alerts - newser.com
BridgeBio Pharma to Present Ten Digital Posters on Acoramidis at AHA Scientific Sessions 2025 - Quiver Quantitative
BBIO: HC Wainwright & Co. Reiterates Buy Rating with $90 PT | BBIO Stock News - GuruFocus
BridgeBio (NASDAQ: BBIO) to share 10 AHA 2025 posters on acoramidis ATTRibute-CM data - Stock Titan
HC Wainwright & Co. Reiterates BridgeBio Pharma (BBIO) Buy Recommendation - Nasdaq
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Q3 2025 Earnings Call Transcript - MSN
What moving averages say about BridgeBio Pharma Inc.Weekly Profit Summary & Real-Time Buy Signal Notifications - newser.com
New York Life Investment Management LLC Makes New $548,000 Investment in BridgeBio Pharma, Inc. $BBIO - MarketBeat
Cantor Fitzgerald Issues Positive Estimate for BBIO Earnings - MarketBeat
What is Leerink Partnrs' Estimate for BBIO FY2025 Earnings? - MarketBeat
Can machine learning forecast BridgeBio Pharma Inc. recoveryJuly 2025 News Drivers & Smart Money Movement Alerts - newser.com
Nisa Investment Advisors LLC Sells 4,667 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat
What indicators show strength in BridgeBio Pharma Inc.July 2025 Retail & Verified Momentum Stock Watchlist - newser.com
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
BridgeBio targets 30%+ market share for Attruby while advancing late-stage pipeline and reporting $120.7M Q3 revenue - MSN
Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) Director Sells $13,206,742.22 in Stock - MarketBeat
BridgeBio Pharma, Inc. (BBIO) Stock forecasts - Yahoo! Finance UK
BridgeBio Pharma, Inc. (BBIO) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
BridgeBio Pharma, Inc. (BBIO) Stock Forecasts - Yahoo! Finance Canada
Analyzing BridgeBio Pharma Inc. with risk reward ratio charts2025 Market Overview & Community Consensus Stock Picks - newser.com
BridgeBio Pharma Inc. (BBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
BridgeBio Pharma director sells $13.2m in BBIO stock By Investing.com - Investing.com Canada
Bridgebio Pharma Insider Sold Shares Worth $13,206,528, According to a Recent SEC Filing - MarketScreener
[Form 4] BridgeBio Pharma, Inc. Insider Trading Activity - Stock Titan
BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $95.00 at TD Cowen - MarketBeat
BridgeBio Pharma, Inc. (BBIO) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
BridgeBio Pharma: Bullish On Attruby's Momentum And 2026 Catalysts (BBIO) - Seeking Alpha
BBIO: Goldman Sachs Raises Price Target and Maintains Buy Rating | BBIO Stock News - GuruFocus
Raymond James Financial Reaffirms "Outperform" Rating for BridgeBio Pharma (NASDAQ:BBIO) - MarketBeat
Piper Sandler Issues Positive Forecast for BridgeBio Pharma (NASDAQ:BBIO) Stock Price - MarketBeat
Cantor Fitzgerald Increases BridgeBio Pharma (NASDAQ:BBIO) Price Target to $110.00 - MarketBeat
What is HC Wainwright's Estimate for BBIO FY2026 Earnings? - MarketBeat
Equities Analysts Offer Predictions for BBIO FY2026 Earnings - MarketBeat
BridgeBio Pharma (NASDAQ:BBIO) Given Buy Rating at Truist Financial - MarketBeat
Emerald Mutual Fund Advisers Trust Sells 78,609 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat
Will BridgeBio Pharma Inc. stock pay special dividendsCPI Data & Risk Controlled Swing Trade Alerts - newser.com
Why retail investors favor BridgeBio Pharma Inc. stockTrade Volume Report & Low Risk High Reward Ideas - newser.com
Piper Sandler Maintains BridgeBio Pharma (BBIO) Overweight Recommendation - MSN
Raymond James Reiterates BridgeBio Pharma (BBIO) Outperform Recommendation - Nasdaq
Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) Director Sells 1,641 Shares of Stock - MarketBeat
BBIO: TD Cowen Raises BridgeBio Pharma Target Price to $95 | BBIO Stock News - GuruFocus
BridgeBio Pharma (NASDAQ:BBIO) Releases Earnings Results, Misses Expectations By $0.07 EPS - MarketBeat
BridgeBio Pharma Hits New 52-Week High of $69.48, Up 139.38% - Markets Mojo
BridgeBio Pharma (BBIO) Sees Target Price Rise from Raymond James | BBIO Stock News - GuruFocus
BridgeBio Pharma (NASDAQ:BBIO) Shares Gap UpHere's Why - MarketBeat
BridgeBio Pharma (BBIO) Sees Analyst Rating Updates and Price Target Increase | BBIO Stock News - GuruFocus
Piper Sandler Raises Price Target for BBIO to $98 | BBIO Stock N - GuruFocus
BridgeBio Pharma, Inc. $BBIO Position Trimmed by Emerald Advisers LLC - MarketBeat
FY2027 Earnings Estimate for BBIO Issued By Leerink Partnrs - MarketBeat
Truist Securities Boosts BridgeBio Pharma (BBIO) Price Target to $80 | BBIO Stock News - GuruFocus
BridgeBio Pharma stock price target raised to $75 at Leerink on strong Attruby sales - Investing.com
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):